For decades, body mass index (BMI) has been the dominant tool for defining obesity, despite longstanding concerns that it poorly reflects individual health risk. Growing evidence suggests that the ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime insulin to improve glycemic control.